Non-Squamous Non-small Cell Lung Cancer research hub
3 indexed studies · 2 currently recruiting
- active not recruitingPHASE3
Phase III Study of AK112 for NSCLC Patients
This study looks at a new drug, AK112, combined with standard chemotherapy for a type of lung cancer. It's for people whose cancer has progressed after previous targeted treatment. We want to see if this combination gives better results than chemotherapy alone.
United States · Canada · France - recruitingPHASE3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
This study is looking at new ways to treat advanced non-small cell lung cancer (a type of lung cancer) that has spread. It compares an experimental drug, rilvegostomig, with a standard drug, pembrolizumab, both given with chemotherapy, to see which works better and is safer.
United States · Argentina · Australia - recruitingPHASE2
Study of Crizotinib for ROS1 and MET Activated Lung Cancer
This study looks at a drug called crizotinib for advanced lung cancer where specific gene changes (ROS1 or MET) are found. It aims to see how well the drug works in these patients.
Canada